Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Number of items: 5.

Kim, Myungjin, Kim, Jun Yong, Rhim, Won-Kyu, Cimaglia, Gloria, Want, Andrew, Morgan, James E. ORCID:, Williams, Pete A., Park, Chun Gwon, Han, Dong Keun and Rho, Seungsoo 2024. Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection. Acta Neuropathologica Communications 12 (1) , 65. 10.1186/s40478-024-01777-0

Cimaglia, Gloria, Bevan, Ryan J. ORCID:, Want, Andrew and Morgan, James E. ORCID: 2023. Gene gun DiOlistic labelling of retinal ganglion cells. Mead, B., ed. Retinal Ganglion Cells: Methods and Protocols, Vol. 2708. New York, NY: Springer, n/a. (10.1007/978-1-0716-3409-7_4)

Cimaglia, Gloria 2023. Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma. PhD Thesis, Cardiff University.
Item availability restricted.

Tribble, James R., Otmani, Amin, Sun, Shanshan, Ellis, Sevannah A., Cimaglia, Gloria, Vohra, Rupali, Jöe, Melissa, Lardner, Emma, Venkataraman, Abinaya P., Domínguez-Vicent, Alberto, Kokkali, Eirini, Rho, Seungsoo, Jóhannesson, Gauti, Burgess, Robert W., Fuerst, Peter G., Brautaset, Rune, Kolko, Miriam, Morgan, James E. ORCID:, Crowston, Jonathan G., Votruba, Marcela ORCID: and Williams, Pete A. 2021. Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction. Redox Biology 43 , 101988. 10.1016/j.redox.2021.101988

Cimaglia, Gloria, Votruba, Marcela ORCID:, Morgan, James E. ORCID:, André, Helder and Williams, Pete A. 2020. Potential therapeutic benefit of NAD+ supplementation for glaucoma and age-related macular degeneration. Nutrients 12 (9) , 2871. 10.3390/nu12092871

This list was generated on Sun Jun 23 06:18:25 2024 BST.